Effects of inactivated parapoxvirus ovis on the cumulative incidence of pneumonia and cytokine secretion in foals on a farm with endemic infections caused by Rhodococcus equi

Veterinary Immunology and Immunopathology

Volumn 140, Issue 3-4, 2011, Pages 237-243

  Sturgill, Tracy L ^a   Giguère, Steeve ^a   Franklin, Robert P ^b   Cohen, Noah D ^c   Hagen, Jodi ^d   Kalyuzhny, Alexander E ^d  

^a UNIVERSITY OF GEORGIA   (United States)

^b Weatherford Equine Medical Center   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d R and D Systems Inc   (United States)

Author keywords

Equine; Foal; IFN ; IL 4; Pneumonia; Rhodococcus equi

Indexed keywords

GAMMA INTERFERON; IMMUNOMODULATING AGENT; INACTIVATED PARAPOXVIRUS OVIS; INTERLEUKIN 4; PLACEBO; UNCLASSIFIED DRUG; ZYLEXIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CELL SECRETION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ECHOGRAPHY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FARM ANIMAL; FOAL; INCIDENCE; LUNG LESION; NONHUMAN; OUTCOME ASSESSMENT; PARAPOXVIRUS; PNEUMONIA; RECEIVER OPERATING CHARACTERISTIC; RHODOCOCCUS EQUI; VIRUS INACTIVATION;

ACTINOMYCETALES INFECTIONS; ANIMALS; ANIMALS, NEWBORN; ENDEMIC DISEASES; HORSE DISEASES; HORSES; INTERFERON-GAMMA; INTERLEUKIN-4; PARAPOXVIRUS; PNEUMONIA, BACTERIAL; RHODOCOCCUS EQUI; VACCINES, INACTIVATED; VIRAL VACCINES;

EQUIDAE; OVIS; PARAPOXVIRUS; RHODOCOCCUS EQUI;

EID: 79952192319     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.12.012     Document Type: Article

References (38)

1. Biuk-Rudan N., Sver L., Valpotic I., Vrbanac I., Madic J., Zupancic Z., Vijtiuk N., Pavicic Z. Effect of Baypamun treatment on Aujeszky's disease virus (ADV) transmission in pigs. Acta Vet. Brno. 2004, 73:59-68.
2. Boyd N.K., Cohen N.D., Lim W.S., Martens R.J., Chaffin M.K., Ball J.M. Temporal changes in cytokine expression of foals during the first month of life. Vet. Immunol. Immunopathol. 2003, 92:75-85.
3. Breathnach C.C., Sturgill-Wright T., Stiltner J.L., Adams A.A., Lunn D.P., Horohov D.W. Foals are interferon gamma-deficient at birth. Vet. Immunol. Immunopathol. 2006, 112:199-209.
4. Castrucci G., Osburn B.I., Frigeri F., Ferrari M., Salvatori D., Lo D.M., Barreca F. The use of immunomodulators in the control of infectious bovine rhinotracheitis. Comp. Immunol. Microbiol. Infect. Dis. 2000, 23:163-173.
5. Chaffin M.K., Cohen N.D., Martens R.J. Chemoprophylactic effects of azithromycin against Rhodococcus equi-induced pneumonia among foals at equine breeding farms with endemic infections. J. Am. Vet. Med. Assoc. 2008, 232:1035-1047.
6. Darrah P.A., Hondalus M.K., Chen Q., Ischiropoulos H., Mosser D.M. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect. Immun. 2000, 68:3587-3593.
7. Fachinger V., Schlapp T., Strube W., Schmeer N., Saalmuller A. Poxvirus-induced immunostimulating effects on porcine leukocytes. J. Virol. 2000, 74:7943-7951.
8. Forster R., Wolf G., Mayr A. Highly attenuated poxviruses induce functional priming of neutrophils in vitro. Arch. Virol. 1994, 136:219-226.
9. Friebe A., Siegling A., Friederichs S., Volk H.D., Weber O. Immunomodulatory effects of inactivated parapoxvirus ovis (ORF virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells. J. Virol. 2004, 78:9400-9411.
10. Giguère S., Gaskin J.M., Miller C., Bowman J.L. Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals. J. Am. Vet. Med. Assoc. 2002, 220:59-63.
11. Giguère S., Lee E., Williams E., Cohen N.D., Chaffin M.K., Halbert N., Martens R.J., Franklin R.P., Clark C.C., Slovis N.M. Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R. equi. J. Am. Vet. Med. Assoc. 2010, 237:74-81.
12. Greiner M., Pfeiffer D., Smith R.D. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev. Vet. Med. 2000, 45:23-41.
13. Horohov D.W., Breathnach C.C., Sturgill T.L., Rashid C., Stiltner J.L., Strong D., Nieman N., Holland R.E. In vitro and in vivo modulation of the equine immune response by parapoxvirus ovis. Equine Vet. J. 2008, 40:468-472.
14. Horowitz M.L., Cohen N.D., Takai S., Becu T., Chaffin M.K., Chu K.K., Magdesian K.G., Martens R.J. Application of Sartwell's model (lognormal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection. J. Vet. Int. Med. 2001, 15:171-175.
15. Hurley J.R., Begg A.P. Failure of hyperimmune plasma to prevent pneumonia caused by Rhodococcus equi in foals. Aust. Vet. J. 1995, 72:418-420.
16. Jacks S., Giguère S., Crawford P.C., Castleman W.L. Experimental Infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction. Clin. Vaccine Immunol. 2007, 14:669-677.
17. Jacks S., Giguère S., Prescott J.F. In vivo expression of and cell-mediated immune responses to the plasmid-encoded virulence-associated proteins of Rhodococcus equi in foals. Clin. Vaccine Immunol. 2007, 14:369-374.
18. Kanaly S.T., Hines S.A., Palmer G.H. Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect. Immun. 1996, 64:1126-1132.
19. Kasuga-Aoki H., Takai S., Sasaki Y., Tsubaki S., Madarame H., Nakane A. Tumour necrosis factor and interferon-gamma are required in host resistance against virulent Rhodococcus equi infection in mice: cytokine production depends on the virulence levels of R. equi. Immunology 1999, 96:122-127.
20. Lopez A.M., Hines M.T., Palmer G.H., Alperin D.C., Hines S.A. Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi. Clin. Diagn. Lab. Immunol. 2002, 9:1270-1276.
21. Martens J.G., Martens R.J., Renshaw H.W. Rhodococcus (Corynebacterium) equi: bactericidal capacity of neutrophils from neonatal and adult horses. Am. J. Vet. Res. 1988, 49:295-299.
22. Martens R.J., Cohen N.D., Jones S.L., Moore T.A., Edwards J.F. Protective role of neutrophils in mice experimentally infected with Rhodococcus equi. Infect. Immun. 2005, 73:7040-7042.
23. Martens R.J., Martens J.G., Fiske R.A. Rhodococcus equi foal pneumonia: pathogenesis and immunoprophylaxis. Proc. Am. Assoc. Equine Pract. 1989, 35:189-213.
24. Martens R.J., Martens J.G., Fiske R.A. Failure of passive immunisation by colostrum from immunised mares to protect foals against Rhodococcus equi pneumonia. Equine Vet. J. 1991, 12(Suppl.):19-22.
25. McCracken J.L., Slovis N.M. Use of thoracic ultrasound for the prevention of Rhodococcus equi pneumonia on endemic farms. Proc. Am. Assoc. Equine Pract. 2009, 55:38-44.
26. Patton K.M., McGuire T.C., Fraser D.G., Hines S.A. Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion. Infect. Immun. 2004, 72:7073-7083.
27. Prescott J.F., Patterson M.C., Nicholson V.M., Morein B., Yager J.A. Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein (VapA) in mice. Vet. Microbiol. 1997, 56:213-225.
28. Ryan C., Giguère S., Fultz L., Long M.T., Crawford P.C. Effects of two commercially available immunostimulants on leukocyte function of foals following ex vivo exposure to Rhodococcus equi. Vet. Immunol. Immunopathol. 2010, 138:198-205.
29. Ryan C., Giguère S., Hagen J., Hartnett C., Kalyuzhny A.E. Effect of age and mitogen on the frequency of interleukin-4 and interferon gamma secreting cells in foals and adult horses as assessed by an equine-specific ELISPOT assay. Vet. Immunol. Immunopathol. 2010, 133:66-71.
30. Slovis N.M., McCracken J.L., Mundy G. How to use thoracic ultrasound to screen foals for Rhodococcus equi at affected farms. Proc. Am. Assoc. Equine Pract. 2005, 51:274-278.
31. Stratton-Phelps M., Wilson W.D., Gardner I.A. Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996). J. Am. Vet. Med. Assoc. 2000, 217:68-73.
32. Trinchieri G., Gerosa F. Immunoregulation by interleukin-12. J. Leukoc. Biol. 1996, 59:505-511.
33. Venner M., Reinhold B., Beyerbach M., Feige K. Efficacy of azithromycin in preventing pulmonary abscesses in foals. Vet. J. 2009, 179:301-303.
34. Wagner B., Burton A., Ainsworth D. Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory T(R)1 cell activation and a delay of the Th2 cell response in equine neonates and foals. Vet. Res. 2010, 41:47.
35. Weber O., Siegling A., Friebe A., Limmer A., Schlapp T., Knolle P., Mercer A., Schaller H., Volk H.D. Inactivated parapoxvirus ovis (Orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus. J. Gen. Virol. 2003, 84:1843-1852.
36. Zecconi A., Bronzo V., Casula A., Luzzago C., Moroni P., Piccinini R., Spreafico G. Efficacy of a biological response modifier in preventing Staphylococcus aureus intramammary infections after calving. J. Dairy Sci. 1999, 82:2101-2107.
37. Ziebell K.L., Kretzdorn D., Auer S., Failing K., Schmeer N. The use of Baypamun N in crowding-associated infectious respiratory disease: efficacy of Baypamun N (freeze dried product) in 2-week-old veal calves. Zentralbl. Veterinarmed. B 1997, 44:415-424.
38. Ziebell K.L., Steinmann H., Kretzdorn D., Schlapp T., Failing K., Schmeer N. The use of Baypamun N in crowding associated infectious respiratory disease: efficacy of Baypamun N (freeze dried product) in 4-10 month old horses. Zentralbl. Veterinarmed. B 1997, 44:529-536.